RhythmAnalytics vs ZEUS System (Zio Watch)
AI Verdict
Choose RhythmAnalytics if…
Choose RhythmAnalytics if you are a healthcare provider or integrator seeking an API-driven solution for automated, comprehensive interpretation of cardiac arrhythmias from diverse single-lead ECG data sources. This tool is ideal for enhancing clinical decision support by quickly processing existing ECG data from devices like Holter monitors or compatible wearables to detect over 15 types of arrhythmias.
View RhythmAnalytics →Choose ZEUS System (Zio Watch) if…
Choose the ZEUS System (Zio Watch) if you require an integrated, long-term continuous cardiac monitoring solution specifically designed for detecting and characterizing Atrial Fibrillation (AFib) burden. This system is best for physicians who need a dedicated wearable device for up to 14 days of monitoring, coupled with AI-powered analysis and a comprehensive portal for actionable insights and patient management.
View ZEUS System (Zio Watch) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | RhythmAnalytics | ZEUS System (Zio Watch) |
|---|---|---|
| Pricing | Contact vendor | Contact vendor |
| Deployment | Cloud-based API | Cloud-based system with a wearable device |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ZEUS System (Zio Watch)Tool B (ZEUS System) offers a comprehensive and direct user experience for both patients and clinicians through its Zio Watch wearable, MyZio patient app, and ZioSuite portal and provider mobile app. In contrast, Tool A (RhythmAnalytics) is primarily a cloud-based API designed for integration into other systems, implying its direct usability is more for developers than end-users.
Clinical Value
RhythmAnalyticsTool A (RhythmAnalytics) provides AI-powered automated interpretation of cardiac arrhythmias, detecting over 15 types, including AFib, ventricular arrhythmias, and ectopic beats, with detailed beat-by-beat morphology computation and high accuracy (90.8% sensitivity, 98.2% specificity). While Tool B (ZEUS System) excels in long-term continuous AFib monitoring with proven superior diagnostic yield and 99% physician agreement for its specific use case, Tool A offers a broader scope of arrhythmia interpretation from diverse ECG data sources.
Pricing & Value
ZEUS System (Zio Watch)Both tools require contacting the vendor for pricing, indicating a lack of public transparency. However, Tool B (ZEUS System) explicitly highlights its value proposition by stating it is designed as a 'cost-effective, noninvasive monitoring solution' and has been associated with reduced emergency department and inpatient hospital utilization. Tool A (RhythmAnalytics) mentions being offered as Software-as-a-Service (SaaS) but does not articulate specific cost-saving benefits.
Enterprise Readiness
ZEUS System (Zio Watch)Both tools are FDA-cleared and HIPAA compliant. Tool B (ZEUS System) explicitly states it has a Business Associate Agreement (BAA) and offers a complete ecosystem with EHR integration services, a ZioSuite portal, and mobile apps for streamlined clinical workflows. While Tool A (RhythmAnalytics) is an API designed for integration, Tool B's comprehensive, end-to-end solution with explicit BAA and robust integration features demonstrates a higher level of enterprise readiness as a complete service.
Innovation
ZEUS System (Zio Watch)Tool B (ZEUS System) demonstrates greater innovation through its AI-powered wearable (Zio Watch) for long-term continuous cardiac monitoring, combining ECG and PPG data for AFib detection and characterization, and integrating a patient engagement app. This represents a significant advancement in how cardiac data is collected and managed in a patient's daily life. Tool A (RhythmAnalytics) is innovative in its advanced AI for broad ECG interpretation, but Tool B's approach to data acquisition and patient engagement is more transformative in the monitoring space.
Support & Docs
ZEUS System (Zio Watch)Tool B (ZEUS System) provides explicit 'Instructions for Use' for both the Zio Watch and ZEUS System, a dedicated 'Support' section on its website, and comprehensive ZioSuite portals and apps that inherently include user guidance and documentation. Tool A (RhythmAnalytics), while implying professional support through its SaaS model and partnerships, has less publicly visible or explicitly detailed documentation and support channels for end-users of integrated solutions.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | RhythmAnalytics | ZEUS System (Zio Watch) |
|---|---|---|
| Name | RhythmAnalytics | ZEUS System (Zio Watch) |
| Company | Biofourmis Singapore Pte. | iRhythm Technologies |
| Primary Function | AI-powered cloud-based software for automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support. | FDA-cleared, AI-powered wearable for long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias. |
| Data Source/Input | Single-lead ECG data from compatible FDA-cleared ECG devices (Holter, event recorders, wearable sensors) | Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection |
| Arrhythmias Detected | Over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats) | Atrial Fibrillation (AFib) burden and other cardiac arrhythmias |
| Monitoring Duration | Not specified | Up to 14 days |
Videos
Demos, reviews, and walkthroughs featuring RhythmAnalytics and ZEUS System (Zio Watch).
Frequently Asked Questions
More Comparisons
More matchups featuring RhythmAnalytics or ZEUS System (Zio Watch)
Backers
Who funded each tool's parent company.